## COP: ConocoPhillips - XLE: Energy

### Executive Summary

No thesis match: MRS_20 0.9% below STRENGTH zone (4.0-10.0%); PEG 3.25 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($89.81)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Surprise Gas Hit Adds Momentum to ConocoPhillipsâ€™ Australian Drilling Ops**
- Source: Offshore Engineer Magazine | 20251230T104609 | Bullish | Relevance: 100%
- ConocoPhillips Australia's Charlemont-1 exploration well in the Otway Basin has unexpectedly encountered gas, prompting a temporary halt to drilling to reassess the well design. This discovery builds on the recent success of the Essington-1 well, reinforcing interest in the region's Waarre reservoirs for future gas supply. ConocoPhillips operates the VIC/P79 permit with a 51% interest, alongside Korea National Oil Company and 3D Energi.

**2. ConocoPhillips stock closes higher as oil jumps; inventories and Feb. 5 earnings date in focus**
- Source: ts2.tech | 20251230T050039 | Somewhat-Bullish | Relevance: 100%
- ConocoPhillips (COP) stock closed 1.2% higher as crude oil prices rose over 2%, despite a delayed U.S. report showing increased crude and gasoline inventories. Traders are closely watching overnight oil market movements and the company's upcoming February 5th earnings call for 2026 guidance. Geopolitical tensions contributed to the rise in oil prices, and investors are evaluating whether this will maintain a risk premium in crude or if anticipated looser supply-demand conditions will lead to lower prices in early 2026.

**3. ConocoPhillips to release 4Q earnings report in February**
- Source: Oklahoma Energy Today | 20251229T180824 | Neutral | Relevance: 100%
- ConocoPhillips is set to release its fourth-quarter 2025 earnings in early February, specifically on February 5, 2026, before market open. The company will also host a conference call to discuss 2026 guidance, with investors anticipating the impact of lower crude oil prices on earnings. Despite a year-over-year decline in Q3 2025 earnings, the company highlighted higher production and lower operating costs, and anticipates lower capital and operating costs for 2026 with flat to modest production growth.

**4. UBS Maintains A Buy Rating On ConocoPhillips (COP)**
- Source: Insider Monkey | 20251228T114500 | Bullish | Relevance: 100%
- UBS has maintained a Buy rating on ConocoPhillips (COP) and increased its price target from $117 to $120, citing a stronger outlook for the energy sector in 2026 due to factors like rising prospects for oilfield services and M&A-driven value creation. Mizuho also reaffirmed an Outperform rating, upgrading its price objective to $121 from $120, highlighting undervalued potential in US oil and gas companies based on longer-term fundamentals. ConocoPhillips is an independent US-based exploration and production company.

**5. Boston Trust Walden Corp Has $30.86 Million Position in ConocoPhillips $COP**
- Source: MarketBeat | 20251230T100704 | Somewhat-Bullish | Relevance: 100%
- Boston Trust Walden Corp reduced its stake in ConocoPhillips (NYSE:COP) by 19.2% during the third quarter, holding 326,196 shares valued at $30.86 million. Despite this, other institutional investors increased their holdings, and 82.36% of the stock is currently owned by institutions. ConocoPhillips reported strong financial results, beat earnings estimates, and announced an increased quarterly dividend.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | UBS | $120 | $117 | +3% |
| 2025-12-12 | Mizuho | $121 | $120 | +1% |
| 2025-12-05 | Johnson Rice | $105 | $108 | -3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | UBS | main | Buy |
| 2025-12-12 | Mizuho | main | Outperform |
| 2025-12-05 | Johnson Rice | down | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 6 ($27.72M) |
| Sells | 4 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 44.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 9.7% (-1.1%)
- Blackrock Inc.: 7.2% (-3.1%)
- State Street Corpora: 5.3% (-2.5%)
- JPMORGAN CHASE & CO: 5.2% (+68.7%)
- Capital Internationa: 3.7% (+18.2%)

### Key Risks

1. Valuation stretched: PEG 3.3x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +1.5% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 3.25 signals overvaluation risk, limited margin of safety. Revenue declining -6% YoY, concerning. Insider buying signal ($27.7M), management confidence. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $117.5B |
| Beta | 0.33 |
| 52W Range | $79.88 - $106.20 |
| Short Interest | 1.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.25 |
| Forward P/E | 15.1 |
| Current P/E | 14.4 |
| YoY Growth | -4.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -0.6% to 0.9% (+1.5% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.1pp (needs >4.0% for momentum thesis). MRS_5 at 2.2% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 56. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 0.90% (CS: 65) | Neutral |
| RSI_14 | 55.8 | Neutral |
| MACD Histogram | -0.18 | Bearish |
| vs SMA20 | 1.010x | Above |
| vs SMA50 | 1.044x | Above |
| vs SMA200 | 1.021x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $94.15
- **Stop Loss:** $89.81 (4.6% risk)
- **Target:** $98.49 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 253
- **Position Value:** $23,819.95
- **Portfolio %:** 23.82%
- **Risk Dollars:** $1,100.00
- **Risk Per Trade:** 1.10%
- **Modifiers:** L1 110% | L2 100% | Combined 1.10x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-02-05 (Est: $1.28)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.41 | $1.61 | +14.1% |
| 2025Q2 | $1.36 | $1.42 | +4.7% |
| 2025Q1 | $2.05 | $2.09 | +2.0% |
| 2024Q4 | $1.83 | $1.98 | +7.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*